MENU
CRNX
AS OF
Dec 26, 04:59 PM (EDT)
Price
$47.94
Change
-$0.77 (-1.58%)
Capitalization
4.62B
68 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
CRNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Crinetics Pharmaceuticals (CRNX) Ownership - Who owns Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
6055 Lusk Boulevard
Phone
+1 858 450-6464
Employees
290
Web
https://www.crinetics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.62B
P/E Ratio
N/A
Total Cash
1.09B
Projected Growth
N/A
Total Debt
49.14M
Revenue
1.54M
Risk (Beta)
-0.53
Dividend Yield
N/A
Total Cash/Share
11.51
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price

Fundamentals

CRNX
Capitalization
4.62B
P/E Ratio
N/A
Risk (Beta)
-0.53
Dividend Yield
N/A
Total Cash
1.09B
Total Cash/Share
11.51
Total Debt
49.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
1.54M
ROE
N/A
Book Value
1.07B
P/B Ratio
4.31
Cash Flow
N/A
Earnings
-4.53
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.37B
Current Ratio
15.12
Current Revenue Per Employee
327.23
Dividends Per Share - Security
N/A
EBITDA
-474.16M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-39.66
Shares Held By Institutions
7.14B
Shares Outstanding - Current
94.9M
Total Liabilities
124M
Total Volume MTD
N/A
Value
-1
Gain YTD
-4.733
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CRNX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CRNX showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for CRNX
A.I. Advisor
published General Information

General Information

a developer of therapeutics for endocrine-related diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
6055 Lusk Boulevard
Phone
+1 858 450-6464
Employees
290
Web
https://www.crinetics.com